HAE: Haemonetics Corporation Stock

by  •  • Comments Off on HAE: Haemonetics Corporation Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 4,621.03
Enterprise Value ($M) 5,297.64
Book Value ($M) 943.32
Book Value / Share 18.57
Price / Book 4.90
NCAV ($M) -492.13
NCAV / Share -9.69
Price / NCAV -9.39

Profitability (mra)
Return on Invested Capital (ROIC) 0.07
Return on Assets (ROA) 0.07
Return on Equity (ROE) 0.15

Liquidity (mrq)
Quick Ratio 1.76
Current Ratio 2.92

Balance Sheet (mrq) ($M)
Current Assets 764.98
Assets 2,200.43
Liabilities 1,257.11
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Neuberger Berman Group LLC 6.96 -8.84
02-13 13G/A Vanguard Group Inc 10.65 3.12
02-09 13G/A Capital Research Global Investors 12.90 9.53
02-08 13G/A Wellington Management Group Llp 6.44 -19.00
01-23 13G/A BlackRock Inc. 11.90 2.68

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 30, 2023 ☐ TRANSITION REPORT PURSUANT
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2023 ☐ TRANSITION REPORT PURSUAN
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: July 1, 2023 ☐ TRANSITION REPORT PURSUANT TO S
2023-05-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-29 103,424 417,739 24.76
2024-04-26 129,350 749,023 17.27
2024-04-25 71,484 431,158 16.58
2024-04-24 46,106 238,823 19.31

(click for more detail)

Similar Companies
FNA – Paragon 28, Inc. GKOS – Glaukos Corporation
GMED – Globus Medical, Inc. INSP – Inspire Medical Systems, Inc.
ITGR – Integer Holdings Corporation


Financial data and stock pages provided by
Fintel.io